US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist
  • 1.770
  • -0.160-8.29%
Close Nov 15 16:00 ET
  • 1.810
  • +0.040+2.26%
Post 20:01 ET
78.88MMarket Cap-1164P/E (TTM)

Werewolf Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
-85.86%1.14M
-83.38%742K
21.60%19.94M
-79.39%1.5M
18.65%5.9M
94.82%8.08M
4.46M
16.4M
7.28M
Operating revenue
--0
-85.86%1.14M
-83.38%742K
21.60%19.94M
-79.39%1.5M
18.65%5.9M
94.82%8.08M
--4.46M
--16.4M
--7.28M
Cost of revenue
Gross profit
Operating expense
13.04%17.12M
42.09%20.1M
7.29%17.9M
-16.58%60.45M
-29.32%14.46M
-13.48%15.15M
-26.00%14.15M
8.60%16.69M
44.66%72.46M
14.42%20.46M
Selling and administrative expenses
6.64%4.6M
5.85%4.83M
0.30%5M
-0.14%18.67M
4.58%4.81M
-2.91%4.31M
-12.77%4.57M
12.67%4.98M
26.17%18.7M
2.65%4.6M
-General and administrative expense
6.64%4.6M
5.85%4.83M
0.30%5M
-0.14%18.67M
4.58%4.81M
-2.91%4.31M
-12.77%4.57M
12.67%4.98M
26.17%18.7M
2.65%4.6M
Research and development costs
15.59%12.53M
59.36%15.27M
10.27%12.91M
-22.29%41.78M
-39.16%9.65M
-17.08%10.84M
-30.99%9.58M
6.95%11.71M
52.43%53.76M
18.35%15.86M
Operating profit
-85.10%-17.12M
-212.51%-18.96M
-40.41%-17.16M
27.75%-40.5M
1.65%-12.96M
26.22%-9.25M
59.48%-6.07M
20.45%-12.22M
-11.92%-56.06M
26.31%-13.18M
Net non-operating interest income expense
-63.54%354K
-34.51%651K
-27.99%970K
124.16%4.28M
-18.15%965K
63.74%971K
924.74%994K
3,353.85%1.35M
1,734.62%1.91M
3,567.65%1.18M
Non-operating interest income
-19.01%1.6M
-8.00%1.79M
29.89%1.97M
288.68%7.42M
67.51%1.98M
232.72%1.97M
1,909.28%1.95M
3,794.87%1.52M
1,734.62%1.91M
3,567.65%1.18M
Non-operating interest expense
24.15%1.24M
19.58%1.14M
483.14%1M
--3.14M
--1.01M
--1M
--955K
--172K
--0
----
Other net income (expense)
2,040.00%97K
4,340.00%1.06M
99.91%-1K
-437.87%-1.14M
-108.57%-6K
-266.67%-5K
-108.90%-25K
-6,812.50%-1.11M
338K
70K
Special income (charges)
--0
---553K
----
----
----
--0
--0
----
----
----
-Less:Other special charges
----
--553K
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
2,040.00%97K
6,552.00%1.61M
99.91%-1K
-437.87%-1.14M
-108.57%-6K
-266.67%-5K
-108.90%-25K
-6,812.50%-1.11M
--338K
--70K
Income before tax
-101.24%-16.67M
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
Income tax
Net income
-101.24%-16.67M
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
Net income continuous Operations
-101.24%-16.67M
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
Minority interest income
Net income attributable to the parent company
-101.24%-16.67M
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
-7.66%-53.81M
33.24%-11.93M
Preferred stock dividends
Other preferred stock dividends
0
0
Net income attributable to common stockholders
-101.24%-16.67M
-238.35%-17.25M
-35.14%-16.19M
30.56%-37.37M
-0.61%-12M
30.63%-8.29M
65.07%-5.1M
21.91%-11.98M
73.35%-53.81M
33.24%-11.93M
Basic earnings per share
-65.22%-0.38
-185.71%-0.4
-14.71%-0.39
43.55%-1.05
15.38%-0.33
42.50%-0.23
73.58%-0.14
39.29%-0.34
83.00%-1.86
40.91%-0.39
Diluted earnings per share
-65.22%-0.38
-207.14%-0.43
-14.71%-0.39
43.55%-1.05
15.38%-0.33
42.50%-0.23
73.58%-0.14
39.29%-0.34
83.00%-1.86
40.91%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0-85.86%1.14M-83.38%742K21.60%19.94M-79.39%1.5M18.65%5.9M94.82%8.08M4.46M16.4M7.28M
Operating revenue --0-85.86%1.14M-83.38%742K21.60%19.94M-79.39%1.5M18.65%5.9M94.82%8.08M--4.46M--16.4M--7.28M
Cost of revenue
Gross profit
Operating expense 13.04%17.12M42.09%20.1M7.29%17.9M-16.58%60.45M-29.32%14.46M-13.48%15.15M-26.00%14.15M8.60%16.69M44.66%72.46M14.42%20.46M
Selling and administrative expenses 6.64%4.6M5.85%4.83M0.30%5M-0.14%18.67M4.58%4.81M-2.91%4.31M-12.77%4.57M12.67%4.98M26.17%18.7M2.65%4.6M
-General and administrative expense 6.64%4.6M5.85%4.83M0.30%5M-0.14%18.67M4.58%4.81M-2.91%4.31M-12.77%4.57M12.67%4.98M26.17%18.7M2.65%4.6M
Research and development costs 15.59%12.53M59.36%15.27M10.27%12.91M-22.29%41.78M-39.16%9.65M-17.08%10.84M-30.99%9.58M6.95%11.71M52.43%53.76M18.35%15.86M
Operating profit -85.10%-17.12M-212.51%-18.96M-40.41%-17.16M27.75%-40.5M1.65%-12.96M26.22%-9.25M59.48%-6.07M20.45%-12.22M-11.92%-56.06M26.31%-13.18M
Net non-operating interest income expense -63.54%354K-34.51%651K-27.99%970K124.16%4.28M-18.15%965K63.74%971K924.74%994K3,353.85%1.35M1,734.62%1.91M3,567.65%1.18M
Non-operating interest income -19.01%1.6M-8.00%1.79M29.89%1.97M288.68%7.42M67.51%1.98M232.72%1.97M1,909.28%1.95M3,794.87%1.52M1,734.62%1.91M3,567.65%1.18M
Non-operating interest expense 24.15%1.24M19.58%1.14M483.14%1M--3.14M--1.01M--1M--955K--172K--0----
Other net income (expense) 2,040.00%97K4,340.00%1.06M99.91%-1K-437.87%-1.14M-108.57%-6K-266.67%-5K-108.90%-25K-6,812.50%-1.11M338K70K
Special income (charges) --0---553K--------------0--0------------
-Less:Other special charges ------553K--------------------------------
Other non- operating income (expenses) 2,040.00%97K6,552.00%1.61M99.91%-1K-437.87%-1.14M-108.57%-6K-266.67%-5K-108.90%-25K-6,812.50%-1.11M--338K--70K
Income before tax -101.24%-16.67M-238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M
Income tax
Net income -101.24%-16.67M-238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M
Net income continuous Operations -101.24%-16.67M-238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M
Minority interest income
Net income attributable to the parent company -101.24%-16.67M-238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M-7.66%-53.81M33.24%-11.93M
Preferred stock dividends
Other preferred stock dividends 00
Net income attributable to common stockholders -101.24%-16.67M-238.35%-17.25M-35.14%-16.19M30.56%-37.37M-0.61%-12M30.63%-8.29M65.07%-5.1M21.91%-11.98M73.35%-53.81M33.24%-11.93M
Basic earnings per share -65.22%-0.38-185.71%-0.4-14.71%-0.3943.55%-1.0515.38%-0.3342.50%-0.2373.58%-0.1439.29%-0.3483.00%-1.8640.91%-0.39
Diluted earnings per share -65.22%-0.38-207.14%-0.43-14.71%-0.3943.55%-1.0515.38%-0.3342.50%-0.2373.58%-0.1439.29%-0.3483.00%-1.8640.91%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data